# OnCo record cyclacel (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cyclacel/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cyclacel" ;
  schema:name "Cyclacel Pharmaceuticals"@en ;
  schema:alternateName "Cyclacel Pharmaceuticals, Inc."@en, "Cyclacel"@en ;
  schema:description "Cyclacel is a cell-cycle drug company whose nucleoside analogue sapacitabine failed its phase 3 trial in older patients with acute myeloid leukaemia; it now develops CDK and PLK inhibitors."@en ;
  schema:url <https://onco.cc/companies/cyclacel/>, <http://www.cyclacel.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cyclacel> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5198104> ;
  schema:citation <http://www.cyclacel.com>, <https://clinicaltrials.gov/search?lead=Cyclacel%20Pharmaceuticals%2C%20Inc.>, <https://www.wikidata.org/wiki/Q5198104> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .